Muller & Phipps (India) Ltd.

Muller & Phipps (India) Ltd.

BBSE:MULLER
204.80
INR
+5.30
(+2.66%)
-10.07EPS
132.41MMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
58.98
72.48
55.99
54.94
50.23
59.85
57.85
63.59
58.71
62.61
66.25
94.66
90.11
98.66
Basic EPS, GAAP
-3.76
7.08
-1.13
0.63
-0.55
3.07
5.63
27.63
6.96
3.4
11.65
-12.11
-0.76
-10.07
Free Cash Flow per Basic Share
-1.26
8.35
0.44
0.98
2.28
-0.22
1.94
34.32
1.72
3.28
11.32
-6.78
1.9
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-85.35
-78.27
-79.4
-78.36
-78.75
-75.52
-69.76
-42.56
-35.68
-32.35
-20.78
-33.24
-33.26
- -
Tangible Book Value per Share
-85.35
-78.27
-79.4
-78.36
-78.75
-75.52
-69.76
-42.56
-35.68
-32.35
-20.78
-33.24
-33.26
- -
Basic Weighted Avg Shares
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Sales/Revenue/Turnover
37
45
35
34
31
37
36
40
37
39
41
59
56
62
Operating Margin (%)
1.63
8.14
-1.2
-0.16
2.86
9.81
2.77
6.32
4.6
1.05
-0.78
-11.44
-21.84
-17.4
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-2
4
-1
- -
- -
2
4
17
4
2
7
-8
- -
-6
Effective Tax Rate (%)
- -
0.56
- -
25.79
- -
19.33
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-6.37
9.77
-2.02
1.14
-1.1
5.13
9.73
43.45
11.85
5.43
17.58
-12.79
-0.84
-10.21
Working Capital
-62
-56
-39
-39
-39
-37
-37
-15
-15
-15
-11
-18
-19
- -
LT Debt
- -
- -
19
19
19
20
19
16
13
10
8
8
8
- -
Total Equity
-53
-49
-50
-49
-49
-47
-44
-27
-22
-20
-13
-21
-21
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
-24.99
- -
-61.74
- -
-12.45
-18.91
-103.59
-54.02
-31.21
-105.15
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
- -
- -
LT Borrowings
- -
8
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1
1
1
Market Capitalization
153
119
132

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
22
- -
Cash, Cash Equivalents & STI
- -
1
- -
Accounts Receivable, Net
- -
18
- -
Inventories
- -
2
- -
Total Current Liabilities
- -
41
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-5.28%
-0.25%
0.07%
Free Cash Flow
77.42%
-9.29%
-128.09%
Net Income, GAAP
-70.56%
-36.14%
-93.72%
Sales/Revenue/Turnover
5.81%
8.57%
-4.81%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
15
12
15
17
59
2026
9
18
14
15
56
2027
15
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
0.99
-3.71
-1.92
-7.47
-12.11
2026
11.16
-0.5
-6.18
-5.25
-0.76
2027
1.83
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

CEO
V. Mohan
Full Time Employees
35
Sector
Distribution services
Industry
Wholesale distributors
Address
Madhva Commercial Premises Mumbai MA India 400051
IPO Date
Aug 10, 2005
Business
Muller & Phipps (India) Limited (MULLER.BO) markets and distributes over-the-counter medical preparations and home care products throughout India; its core offerings include Cavisan Medicated Dental Cream, Cavifast Medicated Dental Gel, Cavisan Gum Astringent, and Nixoderm skin care products, with additional consumer and OTC pharmaceutical items marketed via an extensive distribution network covering approximately 40,100 chemists, 65,700 general stores, 82,450 provisional and kirana stores, and 2,345 supermarkets across major cities such as Mumbai, Delhi, Chennai, Kolkata, Bangalore, Hyderabad, and others. Founded in 1917 and headquartered at 204 Madhava Commercial Premises, C-4 Bandra Kurla Complex, Bandra East, Mumbai, the company operates as a trading entity with state-level sales offices led by dedicated managers, providing warehousing, despatching, and brand marketing services to principals in the consumer products and pharma segments. In recent developments, the company reported unaudited financial results for the quarter ended June 30, 2025, approved its Annual General Meeting for September 23, 2025, and made appointments to its board of directors and company secretary roles, while its affiliated Middle East group pursued strategic expansions including the acquisition of Power League Gaming assets in 2024 to bolster technology distribution and esports capabilities in the MENA region.